Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective
Background Ustekinumab is an interleukin 12/23 inhibitor, approved by the US-FDA for the management of moderate-to-severe plaque psoriasis and psoriatic arthropathy. Purpose This review aims to describe the dermatological implications and applications of ustekinumab. Methodology PubMed and Google Sc...
Saved in:
Published in | Journal of Pharmacology and Pharmacotherapeutics Vol. 15; no. 2; pp. 105 - 121 |
---|---|
Main Authors | , |
Format | Book Review Journal Article |
Language | English |
Published |
New Delhi, India
SAGE Publications
01.06.2024
Sage Publications Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!